Endovascular Treatment of Renal Artery Thrombosis in Living-Donor Kidney Transplant Recipient With Severe COVID-19 Disease.
J Endovasc Ther
; 29(6): 966-970, 2022 12.
Article
in English
| MEDLINE | ID: covidwho-1613202
ABSTRACT
PURPOSE:
Coronavirus disease 2019 (COVID-19) patients have a higher prevalence of micro-and macrovascular thrombotic events. However, the underlying mechanism for the increased thrombotic risk is not completely understood. Solid organ transplant recipients infected with SARS-CoV-2 may have an exponential increase in thrombotic risk and the best management strategy is unknown. CASE REPORT A female kidney transplant recipient presented with allograft's renal artery thrombosis after a recent COVID-19 infection. Due to the risk of kidney failure or exclusion, catheter directed thrombolysis was performed. Residual thrombus was excluded using an endoprosthesis with an excellent result. There were no adverse events and kidney function improved.CONCLUSION:
This paper reports the endovascular treatment of renal artery thrombosis in a living-donor kidney transplant recipient with severe COVID-19 disease.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Thrombosis
/
Kidney Transplantation
/
COVID-19
Type of study:
Case report
/
Observational study
/
Prognostic study
Limits:
Female
/
Humans
Language:
English
Journal:
J Endovasc Ther
Journal subject:
Vascular Diseases
Year:
2022
Document Type:
Article
Affiliation country:
15266028211068756
Similar
MEDLINE
...
LILACS
LIS